|4Apr 1, 9:31 AM ET

Gagnon Suzanne 4

4 · Panbela Therapeutics, Inc. · Filed Apr 1, 2021

Insider Transaction Report

Form 4
Period: 2021-03-30
Gagnon Suzanne
DirectorChief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-03-30+35,00035,000 total
    Exercise: $4.09Exp: 2031-03-30Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]The stock option is exercisable in three substantially equal installments on the first, second and third anniversaries of the date of grant (March 30, 2022, 2023 and 2024).

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4